|
Martinez-Banaclocha H, Pelegrin P. Detection of Inflammasome Activation by P2X7 Purinoceptor Activation by Determining ASC Oligomerization. Methods Mol Biol. 2020;2041:335-343. doi: 10.1007/978-1-4939-9717-6_25. PubMed PMID: 31646501.
AÑO: 2020
|
31646501
|
Ruiz-Alcaraz AJ, Martinez-Banaclocha H, Marin-Sanchez P, Carmona-Martinez V, Iniesta-Albadalejo MA, Tristan-Manzano M, Tapia-Abellan A, Garcia-Penarrubia P, Machado-Linde F, Pelegrin P, Martinez-Esparza M. Isolation of functional mature peritoneal macrophages from healthy humans. Immunol Cell Biol. 2020 Feb;98(2):114-126. doi: 10.1111/imcb.12305. Epub 2019 Dec 6. PubMed PMID: 31709677.
AÑO: 2020; IF: 5.853
|
|
Valera-Perez A, Tyrkalska SD, Viana C, Rojas-Fernandez A, Pelegrin P, Garcia-Moreno D, Perez-Oliva AB, Mulero V. WDR90 is a new component of the NLRC4 inflammasome involved in Salmonella Typhimurium resistance. Dev Comp Immunol. 2019 Nov;100:103428. doi: 10.1016/j.dci.2019.103428. Epub 2019 Jul 2. PubMed PMID: 31276698.
AÑO: 2019; IF: 3.605
|
|
Malhotra S, Costa C, Eixarch H, Keller CW, Amman L, Martinez-Banaclocha H, Midaglia L, Sarro E, Machin-Diaz I, Villar LM, Trivino JC, Oliver-Martos B, Parlade LN, Calvo-Barreiro L, Matesanz F, Vandenbroeck K, Urcelay E, Martinez-Gines ML, Tejeda-Velarde A, Fissolo N, Castillo J, Sanchez A, Robertson AAB, Clemente D, Prinz M, Pelegrin P, Lunemann JD, Espejo C, Montalban X, Comabella M. NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients. Brain. 2020 May 1;143(5):1414-1430. doi: 10.1093/brain/awaa084. PubMed PMID: 32282893.
AÑO: 2020; IF: 13.501
|
|
Martin-Nalda A, Fortuny C, Rey L, Bunney TD, Alsina L, Esteve-Sole A, Bull D, Anton MC, Basagana M, Casals F, Deya A, Garcia-Prat M, Gimeno R, Juan M, Martinez-Banaclocha H, Martinez-Garcia JJ, Mensa-Vilaro A, Rabionet R, Martin-Begue N, Rudilla F, Yague J, Estivill X, Garcia-Patos V, Pujol RM, Soler-Palacin P, Katan M, Pelegrin P, Colobran R, Vicente A, Arostegui JI. Severe Autoinflammatory Manifestations and Antibody Deficiency Due to Novel Hypermorphic PLCG2 Mutations. J Clin Immunol. 2020 Oct;40(7):987-1000. doi: 10.1007/s10875-020-00794-7. Epub 2020 Jul 15. PubMed PMID: 32671674; PubMed Central PMCID: PMC7505877.
AÑO: 2020; IF: 9.1
|